Xeriant, Inc.: Form 10-Q for the period ended Dec 31, 2022
Filed with the SEC on Feb 16, 2023 and accepted by EDGAR at Feb 16, 2023, 06:02 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 3 months2022-10-01 to 2022-12-31 | $0 | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2022-07-01 to 2022-12-31 | $0 | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2022-10-01 to 2022-12-31 | −$539.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2022-07-01 to 2022-12-31 | −$1.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2022-10-01 to 2022-12-31 | $0 | us-gaap:InterestExpense |
| Interest expense | 6 months2022-07-01 to 2022-12-31 | $0 | us-gaap:InterestExpense |
| Net income | 3 months2022-10-01 to 2022-12-31 | −$1.3m | us-gaap:NetIncomeLoss |
| Net income | 6 months2022-07-01 to 2022-12-31 | −$6.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 6 months2022-07-01 to 2022-12-31 | −$0.02 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 6 months2022-07-01 to 2022-12-31 | −$0.02 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 6 months2022-07-01 to 2022-12-31 | 369,415,435 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2022-07-01 to 2022-12-31 | −$943.8k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2022-07-01 to 2022-12-31 | $2.6k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2022-12-31 | $119.6k | us-gaap:Cash |
| Current assets | At period end2022-12-31 | $250.6k | us-gaap:AssetsCurrent |
| Total assets | At period end2022-12-31 | $363.1k | us-gaap:Assets |
| Current liabilities | At period end2022-12-31 | $6.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-12-31 | $6.3m | us-gaap:Liabilities |
| Shareholders' equity | At period end2022-12-31 | −$3.1m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001477932-23-001086. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.